But skepticism about AI’s impact on jobs, combined with perceptions about data centers’ disruptive impacts on communities, ...

David Sacks argues the viral Anthropic resignation that sparked a global AI-safety panic is not what it appears. He claims the 150-million-view ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

IntroductionIn June 2026, Zscaler ThreatLabz identified a new malware family, tracked as SloppyRAT, that is likely leveraged by a ransomware-related threat actor. ThreatLabz observed SloppyRAT being ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Beverly is a writer, editor, and paralegal specializing in personal finance and tax law. She covers personal financial and legal topics, as well as tax breaks, tax preparation software, and tax law ...

Anthropic CEO Dario Amodei called for a slowdown in frontier AI capability development in a September essay, warning that ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

John Schulman, Beren Millidge, and Charlie O'Neill — sat down with Dwarkesh Patel to argue about why 2036 might ...